Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,035 | 70,074 | 58,106 | 47,410 | 46,139 |
| Marketable Securities | 41,248 | 31,386 | 24,757 | 15,415 | 8,599 |
| Receivables | 34,572 | 31,617 | 26,544 | 27,659 | 15,687 |
| Inventories | 35,553 | 35,236 | 34,781 | 31,441 | 24,706 |
| Income taxes - deferred | N/A | N/A | N/A | 4,079 | 4,045 |
| TOTAL | $191,811 | $174,295 | $146,431 | $128,686 | $102,214 |
| Non-Current Assets | |||||
| PPE Net | 35,479 | 33,846 | 29,872 | 24,104 | 17,434 |
| Investments And Advances | 29,841 | 22,891 | 23,262 | 26,683 | 20,560 |
| Other Non-Current Assets | 18,083 | 17,153 | 15,556 | 8,678 | 9,658 |
| TOTAL | $83,403 | $73,890 | $68,690 | $59,465 | $47,652 |
| Total Assets | $275,214 | $248,185 | $215,121 | $188,151 | $149,866 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 30,626 | 28,434 | 27,454 | 24,534 | 15,070 |
| Accrued Expenses | 39,427 | 36,479 | 18,222 | 18,654 | 13,264 |
| TOTAL | $70,053 | $64,913 | $45,676 | $43,188 | $28,334 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,736 | 3,736 | 3,778 | 0 | 0 |
| TOTAL | $3,736 | $3,736 | $3,778 | $N/A | $N/A |
| Total Liabilities | $73,789 | $68,649 | $49,454 | $43,188 | $28,334 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,850 | 71,426 | 70,919 | 69,916 | 69,020 |
| Common Shares | 718 | 713 | 707 | 348 | 345 |
| Retained earnings | -37,699 | -47,112 | -51,056 | -60,405 | -71,910 |
| Other shareholders' equity | -38 | -17 | -45 | -41 | -26 |
| TOTAL | $201,425 | $179,536 | $165,667 | $144,963 | $121,532 |
| Total Liabilities And Equity | $275,214 | $248,185 | $215,121 | $188,151 | $149,866 |